Usability and Clinical effectiveness of the NEVERMIND system

The data provided is from the NEVERMIND trial, a randomized controlled trial to assess the effectiveness of the NEVERMIND system in reducing depressive symptoms among individuals with severe somatic conditions. The dataset includes data on 255 patients diagnosed with breast cancer or prostate cancer who were randomly assigned to the NEVERMIND intervention or a control group. The data includes baseline sociodemographic data, structured questionnaires on mental health symptoms (Beck Depression Inventory-II and Depression, Anxiety and Stress Scale-21), acceptability and usability (System Usability Scale, user version of the Mobile Application Rating Scale, Perceived usefulness and Perceived ease of use) and recorded log data collected at 12 weeks to assess the effectiveness, usability, and acceptability of the NEVERMIND system.

The NEVERMIND system consists of a shirt and a smart phone. Sensors in the shirt and an application in the smart phone data collect data on the patient's condition.

The main purpose of the dataset is to investigate the relationship between the clinical effectiveness, usability, and acceptability of the NEVERMIND eHealth intervention for treating depressive and stress symptoms in breast and prostate cancer patients. Linear mixed model analyses and multiple regression were used to evaluate the association between clinical effectiveness, usability, and acceptability variables.

The dataset is relevant for reuse by researchers interested in investigating the effectiveness of eHealth interventions for treating depressive and stress symptoms in cancer patients.

The dataset consists of a file called dataset_usability_clinical_nevermind.xlsx, which contains a table with data collected from individuals in the study. A codebook file (Codebook.xlsx) is also included and defines the variables used in the table.